-Down to Earth TB programme grappling with lack of funds; weak enforcement of standards another problem A joint initiative of the government, independent experts and civil society has found that multidrug-resistant tuberculosis (MDR-TB) is emerging as a major health problem in India. Moreover, delay in treatment of MD-RTB is the main reason behind increasing antibiotic resistance, especially towards drug Rifampicin. The findings have been established by Joint Monitoring Mission (JMM) 2015 of...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...

A change of strategy for treating patients suffering from tuberculosis has cured 36 million people worldwide and saved up to 8 million lives over the last decade and a half, according to data released today by the United Nations World Health Organization (WHO). “Fifteen years of TB investments are bringing visible results in terms of human lives saved,” said Director of the WHO Stop TB Department Mario Raviglione. “Together, national...

KEY TRENDS    • The 2019 India TB report says that the country accounted for a quarter of the global tuberculosis (TB) burden with an estimated 27 lakh cases in 2018. In 2018, the country was able to achieve a total notification of 21.5 lakh TB cases, of which 25 percent was from private sector. Majority of the TB burden is among the working age group. Nearly 89 percent of TB cases came from the age group 15-69 years....